GlassScriptPhysician profile
Mark Lewis Dunleavy
NPI 1689165318
$13,565.79
in general payments reported to CMS, 2019-2025
14 companies · $1,144 in 2025
The $1,144 reported for 2025 was less than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
See the full distribution for Adult Reconstructive Orthopaedic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $73.73 · 2020: $300 · 2021: $32.98 · 2022: $418 · 2023: $5,766 · 2024: $5,831 · 2025: $1,144.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,321 · Grant: $4,167 · Food and Beverage: $3,527 · Travel and Lodging: $727.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,320.70 |
| Grant | $4,166.67 |
| Food and Beverage | $3,527.27 |
| Travel and Lodging | $726.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $8,465.33 | 2023-2025 | Renasys Touch, Pico 14 |
| Stryker Corporation | $2,143.75 | 2019-2025 | Mako, Tritanium, Insignia |
| Zimmer Biomet Holdings, INC. | $1,177.53 | 2023-2025 | Oxford, G7, Persona |
| Medtronic, INC. | $449.17 | 2023-2024 | Aquamantys(Tm) |
| Medical Device Business Services, INC. | $300.00 | 2020 | |
| Linkbio Corp | $198.73 | 2024 | |
| Medacta USA, INC. | $167.17 | 2023 | Amistem |
| Omnilife Science, INC | $166.90 | 2023-2024 | Omnibotics 3.0, Various Products |
| Avanos Medical | $146.83 | 2023 | On-Q* Pump and Accessories |
| Encore Medical, LP | $126.63 | 2025 | |
| Globus Medical, INC. | $123.22 | 2022 | |
| Novus Surgical Solutions LLC | $50.84 | 2022 | |
| Organogenesis INC. | $28.47 | 2025 | Simplimax |
| E.R. Squibb & Sons, L.L.C. | $21.22 | 2024 | Opdivo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Dunleavy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.